Candidate Engagement Pipeline
Outreach & Notification Tracker
Monitor patient inquiries dispatched from recruit.eligara.ai to patients on sites.eligara.ai. When patients opt in, their contact coordinates are unlocked below.
Patient Interested • Ready to Connect
1 Candidate
Contact preference unlocked
Pending Patient Review
1 Candidate
Awaiting in-app response
Total Inquiries Sent
2 Inquiries
Across active trial campaigns
Candidate #PT-4109
✓ Patient Opted In: Interested in Trial
Responded: 2026-09-07 09:20 EST
Recurrent Stage IV NSCLC (EGFR L858R) • 92% Match
Trial: Phase 2 Study of Targeted Combination Therapy in EGFR-Mutated Advanced NSCLC (NCT05481234)
🔓 Direct Contact Coordinates Unlocked
Patient Consent Granted • Authorized Contact Info
Patient Name / Alias: Robert D.
Direct Phone: +1 (617) 555-0192
Location: Newton, MA (8.5 miles from Dana-Farber)
Note from Patient:
"Yes, I am very interested in exploring this trial with Dr. Chen's team. Please contact my care coordinator."
Candidate #PT-9481
In-App Notification Sent • Awaiting Patient Response
Sent: 2026-09-07 14:30 EST
Stage IV Non-Small Cell Lung Cancer (Adenocarcinoma, EGFR Exon 19 del) • 96% Match
Trial: Phase 2 Study of Targeted Combination Therapy in EGFR-Mutated Advanced NSCLC (NCT05481234)
Pending Patient Action
Sent Message:
"Our clinical research team at Dana-Farber Cancer Institute reviewed your de-identified case summary on Eligara and identified your clinical profile as a potential match for our enrolling targeted therapy trial (NCT05481234)..."
🔒 Contact details are encrypted until patient confirms interest.
View Patient's Pending Alert on sites.eligara.ai →